Kopra Bio
Genetically engineered viruses that teach your immune system to kill…
About Kopra Bio
Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using tech we developed at UCSF. We’re making the next Keytruda ($25B/yr cancer drug blockbuster) starting with the most aggressive form of brain cancer, glioblastoma. In the most challenging brain cancer model, we improve survival from 0% with the current FDA approved treatment to 90% with our treatment.
Company details
Funding
Total raised
$9.7M
Last stage
Seed
Investors
Founders
Alexander Haddad
Neurosurgery resident @ UCSF, scientific co-founder @ Kopra Bio. Published over 70 peer-reviewed publications as a neurosurgery resident at UCSF. Alex is particularly interested in the delivery of cell and gene therapies to the central nervous system and neuro-oncology. Kopra Bio is a serial biotech entrepreneur and a UCSF Neurosurgery resident on a mission to revolutionize cancer treatment.
Andrew Bartynski
Serial biotech entrepreneur and repeat YC founder. Previously COO at YourChoice Therapeutics (YC W19, male contraceptive pill) and ANA Therapeutics (COVID-19 antiviral, Phase II/III in <6 months). Holds a PhD.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.